<DOC>
	<DOC>NCT00853983</DOC>
	<brief_summary>The aim of this study is to show how the body absorbs, metabolises and excretes the drug [14C]AZD0530. As for all clinical trials, safety and tolerability of the drug will be evaluated.</brief_summary>
	<brief_title>Phase I Study to Assess Absorption, Metabolism &amp; Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Saracatinib</mesh_term>
	<criteria>Regular Daily Bowel movements Veins suitable for cannulation or repeated venepuncture Presence of any clinically significant illness Abnormal vital signs History or presence of gastrointestinal, hepatic or renal disease or any other condition known to interfere with absorption, distribution, metabolism or excretion of drugs</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>ADME</keyword>
</DOC>